Format

Send to:

Choose Destination
See comment in PubMed Commons below
Curr Protoc Chem Biol. 2012 Dec 1;4(4):311-30. doi: 10.1002/9780470559277.ch120078.

A High-Throughput Screening Method for Identification of Inhibitors of the Deubiquitinating Enzyme USP14.

Author information

  • 1Department of Cell Biology, Harvard Medical School, Boston, Massachusetts.

Abstract

Deubiquitinating enzymes (DUBs) reverse the process of ubiquitination, and number nearly 100 in humans. In principle, DUBs represent promising drug targets, as several of the enzymes have been implicated in human diseases. The isopeptidase activity of DUBs can be selectively inhibited by targeting the catalytic site with drug-like compounds. Notably, the mammalian 26S proteasome is associated with three major DUBs: RPN11, UCH37, and USP14. Because the ubiquitin 'chain-trimming' activity of USP14 can inhibit proteasome function, inhibitors of USP14 can stimulate proteasomal degradation. We recently established a high-throughput screening (HTS) method to identify small-molecule inhibitors specific for USP14. The protocols in this article cover the necessary procedures for preparing assay reagents, performing HTS for USP14 inhibitors, and carrying out post-HTS analysis. Curr. Protoc. Chem. Biol. 4:311-330 © 2012 by John Wiley & Sons, Inc.

KEYWORDS:

26S proteasome; USP14; deubiquitinating enzyme; high‐throughput screening; small‐molecule inhibitor

PMID:
23788557
[PubMed]
PMCID:
PMC3690187
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for John Wiley & Sons, Inc. Icon for PubMed Central
    Loading ...
    Write to the Help Desk